Provide PDF Format
Biosimilars: A Global Perspective of a New Market - Opportunities, Threats and Critical Strategies 2014: Enterprise
- Customers Who Bought This Also Bought
- Report / Survey by Thomson Reuters BioWorld, 09/30/2014
- Publisher: BioWorld
$3,998.00$7,995.00
- Interactive PDF of data, projections, and analysis
- >100 deals involving follow-on biologics (FOBs) identified
- 700 biosimilars and 245 companies profiled
- Updates on approvals and pipeline developments
- Analysis of competitive landscape, defensive strategies, and market share
- Market/regulatory analysis of 25 countries in Europe, Asia/Pacific, Latin America, Middle East, Africa, and North America
- Core drivers and IP issues impacting biosimilar growth
- and much more
Single-user version also available.
Related Products
Biosimilars: A Global Perspective of a New Market - Opportunities, Threats and Critical Strategies 2014: Single User
Customers Who Bought This Also Bought..
$1,998.00 $3,995.00
Biosimilars: A Global Perspective of a New Market - Opportunities, Threats and Critical Strategies 2014: Enterprise
Customers Who Bought This Also Bought..
$3,998.00 $7,995.00